750 related articles for article (PubMed ID: 7913760)
21. Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
Hegde RS; Tremblay P; Groth D; DeArmond SJ; Prusiner SB; Lingappa VR
Nature; 1999 Dec; 402(6763):822-6. PubMed ID: 10617204
[TBL] [Abstract][Full Text] [Related]
22. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
23. Anchors away--of plaques and pathology in prion disease.
Telling G
N Engl J Med; 2005 Sep; 353(11):1177-9. PubMed ID: 16162891
[No Abstract] [Full Text] [Related]
24. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
Cronier S; Laude H; Peyrin JM
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
[TBL] [Abstract][Full Text] [Related]
25. Insights into prion strains and neurotoxicity.
Aguzzi A; Heikenwalder M; Polymenidou M
Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
[TBL] [Abstract][Full Text] [Related]
26. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein.
Collinge J; Palmer MS; Sidle KC; Hill AF; Gowland I; Meads J; Asante E; Bradley R; Doey LJ; Lantos PL
Nature; 1995 Dec 21-28; 378(6559):779-83. PubMed ID: 8524411
[TBL] [Abstract][Full Text] [Related]
27. Prion protein transgenes and the neuropathology in prion diseases.
DeArmond SJ; Prusiner SB
Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
[TBL] [Abstract][Full Text] [Related]
28. Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases.
Jeong BH; Kim NH; Jin JK; Choi JK; Lee YJ; Kim JI; Choi EK; Carp RI; Kim YS
J Neuropathol Exp Neurol; 2009 Aug; 68(8):870-9. PubMed ID: 19606066
[TBL] [Abstract][Full Text] [Related]
29. Normal host prion protein necessary for scrapie-induced neurotoxicity.
Brandner S; Isenmann S; Raeber A; Fischer M; Sailer A; Kobayashi Y; Marino S; Weissmann C; Aguzzi A
Nature; 1996 Jan; 379(6563):339-43. PubMed ID: 8552188
[TBL] [Abstract][Full Text] [Related]
30. Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease.
Brazier MW; Lewis V; Ciccotosto GD; Klug GM; Lawson VA; Cappai R; Ironside JW; Masters CL; Hill AF; White AR; Collins S
Brain Res Bull; 2006 Jan; 68(5):346-54. PubMed ID: 16377442
[TBL] [Abstract][Full Text] [Related]
31. Peripheral circulation of the prion infectious agent in transgenic mice expressing the ovine prion protein gene in neurons only.
Crozet C; Lezmi S; Flamant F; Samarut J; Baron T; Bencsik A
J Infect Dis; 2007 Apr; 195(7):997-1006. PubMed ID: 17330790
[TBL] [Abstract][Full Text] [Related]
32. Is the prion structure solved?
Liberski PP; Bratosiewicz-Zapart J
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):121-40. PubMed ID: 9597078
[TBL] [Abstract][Full Text] [Related]
33. Prion diseases of the central nervous system.
Prusiner SB; DeArmond SJ
Monogr Pathol; 1990; (32):86-122. PubMed ID: 2192281
[TBL] [Abstract][Full Text] [Related]
34. The metabolism of glycosaminoglycans is impaired in prion diseases.
Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
[TBL] [Abstract][Full Text] [Related]
35. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
Uppington KM; Brown DR
J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
[TBL] [Abstract][Full Text] [Related]
36. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.
Chesebro B; Race B; Meade-White K; Lacasse R; Race R; Klingeborn M; Striebel J; Dorward D; McGovern G; Jeffrey M
PLoS Pathog; 2010 Mar; 6(3):e1000800. PubMed ID: 20221436
[TBL] [Abstract][Full Text] [Related]
37. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetics of human prion diseases.
Collinge J; Palmer MS
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):371-8. PubMed ID: 7913754
[TBL] [Abstract][Full Text] [Related]
39. Differences in scrapie-induced pathology of the retina and brain in transgenic mice that express hamster prion protein in neurons, astrocytes, or multiple cell types.
Kercher L; Favara C; Chan CC; Race R; Chesebro B
Am J Pathol; 2004 Dec; 165(6):2055-67. PubMed ID: 15579448
[TBL] [Abstract][Full Text] [Related]
40. Prions in skeletal muscle.
Bosque PJ; Ryou C; Telling G; Peretz D; Legname G; DeArmond SJ; Prusiner SB
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3812-7. PubMed ID: 11904434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
